Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids

Archiv der Pharmazie
Ola H RizkIbrahim A Abdelwahab

Abstract

Antibiotic-resistant bacteria continue to play an important role in human health and disease. Inventive strategies are necessary to develop new therapeutic leads to challenge drug-resistance problems. From this perception, new quinoline hybrids bearing bioactive pharmacophores were synthesized. The newly synthesized compounds were evaluated for their in vitro antibacterial activity against nine bacterial pathogenic strains. The results revealed that most compounds exhibited good antibacterial activities. Seven compounds (2b, 3b, 4, 6, 8b, and 9c,d) displayed enhanced activity against methicillin-resistant Staphylococcus aureus compared to ampicillin. These compounds were subjected to an in vitro S. aureus DNA gyrase ATPase inhibition study, which revealed that compounds 8b, 9c, and 9d showed the highest inhibitory activity with IC50 values of 1.89, 2.73, and 2.14 μM, respectively, comparable to novobiocin (IC50 , 1.636 μM). Compounds 2a-c, 3a, 7c, 9c,d, and 10a,b revealed half the potency of levofloxacin in inhibiting the growth of Pseudomonas aeruginosa. As an attempt to rationalize the observed antibacterial activity for the most active compounds 8b, 9c, and 9d, molecular docking in the ATP binding site of S. aureus gyrase B ...Continue Reading

References

Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Jun 23, 2007·Current Medicinal Chemistry·John B BremnerSiritron Samosorn
Mar 31, 2010·Bioorganic & Medicinal Chemistry·Nafees AhmedKamlesh K Bhutani
May 11, 2010·European Journal of Medicinal Chemistry·Balladka Kunhanna SarojiniHanumanthappa Manjunatha
Jul 8, 2010·European Journal of Medicinal Chemistry·Samir BondockMohamed A Metwally
Jan 29, 2011·The Lancet Infectious Diseases·Marisa H MiceliSamuel A Lee
Sep 10, 2011·Applied Microbiology and Biotechnology·Frédéric CollinAnthony Maxwell
Dec 24, 2013·Bioorganic & Medicinal Chemistry Letters·Chao ChenMichael J Kelso
Dec 3, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Rangappa S Keri, Siddappa A Patil
Jan 17, 2015·Bioorganic & Medicinal Chemistry·Stéphanie Vandekerckhove, Matthias D'hooghe
Aug 22, 2015·European Journal of Medicinal Chemistry·Virginia SpanòPaola Barraja
Oct 16, 2015·Journal of Medicinal Chemistry·Jing ZhangRoland E Dolle
May 24, 2016·Bioorganic & Medicinal Chemistry Letters·Xing ZhangRobert J Linhardt
Nov 9, 2017·European Journal of Medicinal Chemistry·Mohamed F El ShehryYousry A Ammar
Jan 9, 2018·European Journal of Medicinal Chemistry·M Madhu SekharT Vijaya
May 31, 2018·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Nazar TrotskoAnna Malm
Feb 19, 2019·European Journal of Medicinal Chemistry·Davide Benedetto TizNace Zidar

❮ Previous
Next ❯

Citations

Nov 20, 2020·Archiv der Pharmazie·Atukuri Dorababu
Nov 5, 2020·Bioorganic Chemistry·Shalini JaswalVikramdeep Monga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.